由于机构投资者在2025年调整了在Q2的持有量,辉瑞的股票在高收入和高股利上扬,尽管收入略有减少。 Pfizer's stock rose on strong earnings and a high dividend, despite slightly lower revenue, as institutional investors adjusted holdings in Q2 2025.

机构投资者OMERS管理局在第二季度将Pfizer的股份减少了17.7%,出售了61 000股,而Shelton资本管理公司增加了2.8%。 Institutional investor OMERS Administration reduced its stake in Pfizer by 17.7% in the second quarter, selling 61,000 shares, while Shelton Capital Management increased its holding by 2.8%. Pfizer报告说,第二季度收入为每股0.87美元,但收入略微不足。 Pfizer reported second-quarter earnings of $0.87 per share, beating estimates, though revenue fell slightly short. 该公司维持了2025年的全年指导,并支付了0.43美元的季度红利,收益率为6.8%,支付比率100%。 The company maintained its 2025 full-year guidance and paid a $0.43 quarterly dividend, yielding 6.8% with a 100% payout ratio. 该股票于2025年12月2日以25.31美元开放,市场上限为143.88亿美元,并获得一致的“稳住”评级。 The stock opened at $25.31 on December 2, 2025, with a market cap of $143.88 billion and a consensus "Hold" rating.